Emmes, a United States-based full-service Clinical Research Organisation, announced on Monday1, that it has named Dr Paul VanVeldhuisen as the president of Emmes Public Sector.
Dr VanVeldhuisen has more than 25 years of experience in clinical research. He joined Emmes in 1993 and later became a principal investigator. He has held roles of increasing responsibility in the company. Dr VanVeldhuisen has a PhD in epidemiology from The George Washington University, an MS in biostatistics from the University of Washington and a BS in mathematics from Calvin University.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar